Patient-Specific Risk Factors and Clinical Correlates of Euglycemic Diabetic Ketoacidosis in Patients on Sodium-Glucose Co-Transporter-2 Inhibitors

Background: Sodium-Glucose Co-Transporter-2 Inhibitors (SGLT-2i) association with euglycemic diabetic ketoacidosis (EDKA) has been well reported. The underlying mechanism is mainly enhanced lipolysis and ketone bodies’ reabsorption. They also stimulate the pancreatic alpha cells and inhibit the beta...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:J Endocr Soc
Hoofdauteurs: Somagutta, Manoj Reddy, Pormento, Maria Kezia Lourdes L, Hange, Namrata, Khan, Muhammad Adnan, Jain, Molly S, Hanan, Saad, Batti, Erkan, Kaur, Jaspreet, Iloeje, Obumneme Jude, Pagad, Sukrut
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Oxford University Press 2021
Onderwerpen:
Diabetes Mellitus and Glucose Metabolism
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8090176/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvab048.967
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items